商业与经济

Eli Lilly blows past estimates, hikes sales outlook as Zepbound and Mounjaro demand surge again

来源: Business News · 发布于

Eli Lilly blows past estimates, hikes sales outlook as Zepbound and Mounjaro demand surge again
来源: Business News

Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.

Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.

阅读原文来源